Indian, German firms to collaborate on immunoglobulin products: Indian Embassy

Germany's Neovii Biotech and India's VINS Bioproducts will explore collaboration on manufacturing and commercialising immunoglobulin products, including anti-thymocyte globulin used in organ transplantation and certain blood disorders. Facilitated by the Indian Embassy in Berlin, the agreement involves technology transfer to India and could strengthen domestic capabilities in specialised biological products.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/VT6fGIw
via IFTTT